ArticleNature cancer2021

Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia.

Claudie Bosc et al.PubMed ↗Publisher ↗

No numbers read from the abstract.